Delivery Order SPE2DB22D1202-SPE2DB24FVKF4
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $5,432.81 and a performance period ending on May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a total ceiling value of $2,465.80. The contract is a firm fixed-price, non-set-aside award with a completion date of June 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is a firm fixed price delivery order worth $3,255.22 granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a for-profit subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of February 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $2,013.65 and is a firm fixed price contract. The period of performance runs through May 12, 2025. This award is not associated with a set-aside and appears to be open competition....
The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,948.21, is for the delivery of EXFORGE 5-320 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a type of medication, with a ceiling value of $3,989.54 and a performance period ending on July 2, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a $1,155.95 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the provision of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of March 14, 2024 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating it was competitively bid. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,438.83 firm fixed-price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a medical product, with a completion date of January 8, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,817.75 firm fixed price contract is for the delivery of EXFORGE 10-160 MG TABLET 30S, a brand name pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which...